Multidrug resistant strain.
Resistant to ampicillin, amoxicillin/clavulanic acid, ciprofloxacin, cephalothin, doxycycline, gentamicin,
erythromycin, imipenem, methicillin, penicillin, tetracycline, oxacillin azithromycin, clindamycin, ceftriaxone, rifampin, amikacin and tobramycin.
Susceptible to teicoplanin, chloramphenicol, fosfomycin, mupirocin, netilmicin, streptomycin, trimethoprim/sulfamethoxazole, and vancomycin.
Intermediate resistance to minocycline.
As the guidelines provided by Clinical and Laboratory Standards Institute (CLSI) state, resistance to oxacillin implies resistance to other penicillins such as methicillin. The MIC values of Streptomycin and Mupriocin have been tested to be ≥ 1024 μg/mL and 0.5 μg/mL respectively.
Iberian clone of MRSA
SCCmec: Type I
PFGE type: Iberian
spa type Ridom: t051
spa type Kreiswirth: YHFGFMBQBLO
pvl gene amplification: Negative
Phenotypic and genotypic information for ATCC MRSA strains, such as SCCmec, PFGE, or spa typing, is provided for informational purposes only. This information was compiled from testing performed by one or more sources, including ATCC, strain depositor, published data, or contracted research.